Construção de um plano terapêutico multiprofissional para cuidados de pacientes em internação hospitalar / Construction of a multiprofessional therapeutic plan for the care of hospitalized patients / Construcción de un plan terapéutico multiprofesional para el cuidado de pacientes hospitalizados

INTRODUÇÃO: O Plano Terapêutico, trata-se de um plano de cuidado voltado para cada paciente, considerando sua individualidade e integralidade. O impulso a abordar essa temática se deu a partir da aproximação com um dos campos de atuação, enquanto residente em Urgência e Emergência. OBJETIVO: Construir um plano terapêutico multiprofissional para cuidados de pacientes em internação hospitalar. METODOLOGIA: Estudo metodológico, com abordagem quantitativa, desenvolvido em duas etapas: 1) Realização de revisão integrativa sobre a temática de interesse; 2) Elaboração da tecnologia, com suporte de designer gráfico, realizado entre os meses de novembro 2022 a janeiro de 2023. RESULTADOS: Construiu-se o plano terapêutico, contendo seis domínios, compostos por 27 itens. Os itens trazem, os dados pessoais do paciente, ,antecedentes pessoais, medicações contínuas, descrição do plano articulado pela equipe multiprofissional, descrição de possíveis novos terapêutivos e feedback da equipe. CONCLUSÃO: Esse instrumento de trabalho fortalece a troca de saberes das múltiplas especialidades envolvidas no cuidado, além da assistência integral ao paciente.

INTRODUCTION: The Therapeutic Plan is a care plan aimed at each patient, considering their individuality and completeness. The impetus to approach this theme came from the approach with one of the fields of action, while residing in Urgência e Emergência. OBJECTIVE: To build a multidisciplinary therapeutic plan for the care of hospitalized patients. METHODOLOGY: Methodological study, with a quantitative approach, developed in two stages: 1) Conducting an integrative review on the topic of interest; 2) Elaboration of the technology, with the support of a graphic designer, carried out between the months of November 2022 to January 2023. RESULTS: The therapeutic plan was constructed, containing six domains, composed of 27 items. The items bring the patient's personal data, personal history, continuous medications, description of the plan articulated by the multidisciplinary team, description of possible new therapies and team feedback. CONCLUSION: This work instrument strengthens the exchange of knowledge of the multiple specialties involved in care, in addition to comprehensive patient care.

INTRODUCCIÓN: El Plan Terapéutico es un plan de cuidados dirigido a cada paciente, considerando su individualidad e integralidad. El impulso para abordar este tema surgió del acercamiento con uno de los campos de actuación, durante la residencia en Urgência e Emergência. OBJETIVO: Construir un plan terapéutico multidisciplinar para el cuidado de pacientes hospitalizados. METODOLOGÍA: Estudio metodológico, con abordaje cuantitativo, desarrollado en dos etapas: 1) Realización de una revisión integradora sobre el tema de interés; 2) Elaboración de la tecnología, con el apoyo de un diseñador gráfico, realizada entre los meses de noviembre de 2022 a enero de 2023. RESULTADOS: Se construyó el plan terapéutico, que contiene seis dominios, compuestos por 27 ítems. Los ítems traen los datos personales del paciente, historia personal, medicaciones continuas, descripción del plan articulado por el equipo multidisciplinar, descripción de posibles nuevas terapias y feedback del equipo. CONCLUSIÓN: Este instrumento de trabajo refuerza el intercambio de conocimientos de las múltiples especialidades implicadas en la asistencia, además de la atención integral al paciente.

Tyramine exerts hypolipidemic and anti-obesity effects in vivo

Abstract Obesity and dyslipidemia are conditions often associated with cardiovascular risk, inflammation, oxidative stress, and death. Thus, a new approach has been highlighted to promote research and development of pharmacological tools derived from natural sources. Among the most widely studied groups of substances, polyphenols such as tyramine stand out. This study investigated hypolipidemic and anti-obesity properties of tyramine. Oral toxicity evaluation, models of dyslipidemia and obesity were used. To induce dyslipidemia, Poloxamer-407 (P-407) was administered intraperitoneally. In the hypercholesterolemic and obesity model, specific diet and oral tyramine were provided. After 24h of P-407 administration, tyramine 2 mg/kg (T2) decreased triglycerides (TG) (2057.0 ± 158.5 mg/dL vs. 2838 ± 168.3 mg/dL). After 48h, TG were decreased by T2 (453.0 ± 35.47 vs. 760.2 ± 41.86 mg/dL) and 4 mg/kg (T4) (605.8 ± 26.61 760.2 ± 41.86 mg/dL). T2 reduced total cholesterol (TC) after 24h (309.0 ± 11.17 mg/dL vs. 399.7 ± 15.7 mg/dL); After 48h, 1 mg/kg (T1) (220.5 ± 12.78 mg/dL), T2 (205.8 ± 7.1 mg/dL) and T4 (216.8 ± 12.79 mg/dL), compared to P-407 (275.5 ± 12.1 mg/dL). The treatment decreased thiobarbituric acid reactive substances and nitrite in liver, increased superoxide dismutase, reduced the diet-induced dyslipidemia, decreasing TC around 15%. Tyramine reduced body mass, glucose, and TC after hypercaloric feed. Treatment with 5 mg/L (0.46 ± 0.04 ng/dL) and 10 mg/L (0.44 ± 0.02 ng/dL) reduced plasma insulin (1.18 ± 0.23 ng/dL). Tyramine increased adiponectin at 5 mg/L (1.02 ± 0.02 vs. 0.83 ± 0.02 ng/mL) and 10mg/L (0.96 ± 0.04 ng/mL). In conclusion, tyramine has low toxicity in rodents, has antioxidant effect, reduces plasma triglycerides and cholesterol levels. However, further studies should be conducted in rodents and non-rodents to better understand the pharmacodynamic and pharmacokinetic properties of tyramine